Why Nerve Blocks Don’t Work: Causes and Next Steps

Nerve blocks fail for a surprisingly wide range of reasons, from the needle landing in the wrong spot to the patient’s own tissue chemistry working against the anesthetic. Reported success rates span from about 60% to 100% depending on the type of block, the technique used, and the clinician’s experience. That enormous spread tells you something important: a nerve block is not a single standardized procedure with a predictable outcome. Understanding why one might not work, and what can be done about it, starts with recognizing that anatomy, pharmacology, and individual biology all get a vote.

Anatomy Is Not as Predictable as Textbooks Suggest

The most common reason a nerve block falls short is straightforward: the anesthetic did not reach the nerve it was supposed to reach. Nerves do not always sit where anatomy diagrams show them. Variations in how nerves branch, where they travel through muscle and connective tissue, and how they relate to nearby blood vessels and bones are surprisingly common. A narrative review of these variations found that they directly influence needle trajectory, how the anesthetic spreads through tissue, and ultimately whether the block works.¹ When the nerve sits a few millimeters away from its expected position, even a well-placed injection can miss its target entirely.

Ultrasound guidance has dramatically improved accuracy compared to older techniques that relied on nerve stimulation or anatomical landmarks alone. In children with congenital hand deformities, where the anatomy is especially unpredictable, ultrasound-guided blocks succeeded in 96% of cases compared to 64% with nerve stimulation alone.² Even in patients with more typical anatomy, ultrasound-guided blocks are faster and produce longer-lasting numbness. One randomized trial of supraclavicular blocks for upper limb surgery found that the ultrasound group’s sensory block kicked in faster and lasted longer than the nerve-stimulation group’s.³

Being able to see the nerve also means the clinician can use less anesthetic and still get a complete block. A study measuring the minimum effective volume for median nerve blocks found that ultrasound guidance required roughly half the volume that nerve stimulation needed.⁴ Using less drug reduces the risk of side effects while still getting the job done, but only if the clinician can visualize exactly where the needle tip is relative to the nerve.

Why Inflamed Tissue Fights the Anesthetic

If you have ever been told that a dental block “might not work as well” because the tooth is infected, there is real chemistry behind that warning. Local anesthetics are weak bases, and they work best in the slightly alkaline environment of normal tissue. Inflamed tissue is more acidic, and that acidity changes the drug’s behavior at the molecular level. At the lower pH found in infected or inflamed areas, the anesthetic’s ability to penetrate nerve cell membranes drops measurably.⁵

The acidity story is well established, but the full picture is messier. The same study found that anesthetics could still affect nerve cell membranes even at the low pH of inflamed tissue, suggesting that acidity alone does not explain every failure in an infected area. Other inflammatory molecules may independently make nerves harder to numb. For a patient, the practical takeaway is that a block near an active infection or significant inflammation is simply less reliable. Clinicians often account for this by using higher volumes, choosing a block site farther from the inflammation, or opting for a different pain management approach altogether.

Tachyphylaxis and the Problem of Repeated Dosing

Patients who need repeated nerve blocks, whether for chronic pain management or across multiple surgical procedures, sometimes notice that each successive block seems to wear off faster. This is tachyphylaxis, and it is a real pharmacological phenomenon, not just perception. In animal studies, repeated injections of lidocaine at the same dose produced progressively shorter blocks. The drug cleared from the nerve tissue faster with each round, suggesting the body adapts to remove the anesthetic more efficiently over time.⁶

Interestingly, the nerve’s connection to the spinal cord appears to matter for tachyphylaxis. When researchers severed that connection in animal models, the progressive shortening of block duration was largely eliminated, pointing to the central nervous system’s involvement in the adaptation process.⁷ For patients, this means that if you have been getting nerve blocks for chronic pain and they seem to be lasting less and less time, it is not your imagination. Your clinician may need to adjust the drug choice, concentration, or technique rather than simply repeating the same protocol.

When Your Body Works Against the Block

Beyond technique and pharmacology, several patient-specific factors influence whether a nerve block succeeds.

Body habitus: In patients with significant abdominal or regional fat, the target nerve sits deeper, ultrasound image quality drops, and the needle path becomes longer and harder to control. A study on ilioinguinal nerve blocks in obese patients noted that the overlying abdominal tissue made the standard approach technically challenging and potentially unsafe, requiring modified techniques and lower-frequency ultrasound probes.⁸
Scar tissue: Previous surgery, trauma, or radiation can leave scar tissue that crosses tissue planes and traps or distorts nerves. This scarring creates a physical barrier that can prevent the anesthetic from spreading to the nerve or alter the nerve’s position entirely.⁹
Chronic opioid use: People who use opioids long-term appear to require more local anesthetic, and the block takes longer to kick in. A study comparing lidocaine effectiveness in chronic opium users versus non-users found that opioid users needed roughly 60% more lidocaine, and the onset of numbness took nearly twice as long.¹⁰ Longer-term users (four to five years) experienced even greater delays than newer users.
Central sensitization: Some patients have pain processing that has shifted at the level of the spinal cord and brain, not just at the injury site. In a study of knee replacement patients, those with centralized pain had worse function and higher opioid use six months after surgery compared to patients whose pain was primarily peripheral.¹¹ When pain is being amplified centrally, blocking the peripheral nerve signal may simply not be enough.

Central sensitization is worth dwelling on because it explains a frustrating scenario many patients encounter: the block clearly worked (the area is numb), yet they still feel pain. When the brain and spinal cord have become hypersensitive, they can generate or amplify pain signals independent of the original injury site. A peripheral nerve block cannot reach those central mechanisms. Recognizing this pattern early can redirect treatment toward approaches that address central pain processing, such as certain medications, physical therapy, or psychological interventions, rather than simply repeating blocks that keep falling short.

Rare but Real Genetic Resistance

Some people report that local anesthetics have never worked well for them, across different providers, different procedures, and different drugs. While most individual cases turn out to have mundane explanations (anxiety masking as pain, suboptimal technique, or inflammation), a small number of people appear to have genuine genetic resistance. Researchers who performed whole-exome sequencing on a family in which three members had consistent local anesthetic failure identified a mutation in the SCN5A gene, which encodes a voltage-gated sodium channel.¹² Since local anesthetics work by blocking sodium channels, a structural change in those channels could plausibly reduce the drug’s ability to bind and do its job. The unaffected family member did not carry the mutation.

This is still early-stage science, and true genetic resistance is rare enough that it should not be your first assumption if a block fails once. But if you have a consistent lifelong history of local anesthetics not working across multiple settings, it is worth mentioning to your clinician. Documentation of previous failures helps the anesthesia team plan accordingly, whether that means trying alternative drugs, using higher concentrations, or having a backup plan ready from the start.

How Clinicians Test Whether a Block Worked

One underappreciated reason for apparent block failure is that the block was not properly assessed before the procedure began. Testing a block takes time and the right method. A study comparing assessment techniques for brachial plexus blocks found that cold sensation and pinprick testing reached 100% sensitivity at 20 minutes after the injection, but were less reliable at earlier time points.¹³ If surgery starts before the block has had time to fully develop, the patient may experience pain that would have been prevented by waiting a few more minutes.

In dental settings, the assessment challenge is even trickier. For inferior alveolar nerve blocks used before procedures on inflamed teeth, lip numbness alone is not a reliable indicator that the tooth itself is fully blocked. Researchers have used cold tests and electric pulp tests on the actual tooth, then compared those results to whether the patient felt pain during the procedure.¹⁴ A numb lip tells you the nerve trunk was reached, but it does not guarantee that every branch supplying the tooth received enough anesthetic, especially when inflammation is lowering the local pH.

Rebound Pain Is Not the Same as Block Failure

A common source of confusion happens after a successful block wears off. Some patients experience a sudden surge of pain that feels worse than what they expected, and assume the block “didn’t work” or somehow made things worse. This phenomenon, called rebound pain, is distinct from block failure. Current evidence suggests it represents the unmasking of the normal pain response once the anesthetic is gone, rather than some kind of nerve damage or hyperalgesia caused by the block itself.¹⁵

The issue is largely one of preparation. During the hours when the block is active, the patient feels little or no pain and may not take systemic pain medications. When the block wears off, the full inflammatory response hits all at once, creating that alarming spike. Clinicians can mitigate this by ensuring patients have oral or IV pain medications on board before the block is expected to wear off, smoothing the transition rather than letting a gap open. If you have been told your nerve block “failed” but the initial hours were pain-free, rebound pain is a more likely explanation than the block having never worked at all.

Why “Just Give More” Is Not Always an Option

When a block seems incomplete, the intuitive solution is to inject more anesthetic. But local anesthetics have a ceiling imposed by systemic toxicity. These drugs eventually enter the bloodstream, and at high enough plasma concentrations they can cause seizures, cardiac arrhythmias, and even cardiac arrest. A narrative review of local anesthetic dosing for fascial plane blocks found that while most patients stayed below toxic thresholds, several individual patients crossed them, and some experienced neurologic symptoms or seizures.¹⁶

Certain patients are at higher risk. Older adults have reduced clearance of local anesthetics because of decreased blood flow to the liver and kidneys, which means the drug accumulates faster with repeated doses or continuous infusions.¹⁷ Small-framed patients, those with liver disease, and anyone receiving blocks at highly vascular sites are also at elevated risk. The point is that a failed block cannot always be rescued by simply adding volume. The clinician has to weigh the benefit of a potentially more complete block against the risk of pushing the total dose into dangerous territory. Sometimes the safest rescue is a different approach entirely, such as a supplemental block at a different site, local wound infiltration, or systemic pain medication.

Extended-Release Formulations and Duration Gaps

One of the practical limitations of traditional nerve blocks is that they wear off. Most single-injection blocks using standard bupivacaine or ropivacaine last somewhere between eight and 18 hours, depending on the drug, the concentration, and the site. For surgeries with significant post-operative pain lasting several days, that window may not be long enough. Continuous catheter systems can extend the block by dripping anesthetic through a small tube left near the nerve, but they are resource-intensive and prone to mechanical problems. In a randomized trial of shoulder replacement patients, 16% of those with continuous catheters experienced dislodgement or leakage.¹⁸

Liposomal bupivacaine is an extended-release formulation designed to address this duration gap with a single injection. The same shoulder arthroplasty trial found that a single shot of liposomal bupivacaine provided comparable pain relief to a continuous catheter through the third day after surgery, with no difference in opioid consumption and a roughly 28% reduction in cost.¹⁸ Eliminating the catheter also eliminates the catheter-related complications. That said, extended-release formulations do not solve the problem of a block that missed the nerve in the first place. They address duration, not accuracy.

Artificial Intelligence in Nerve Block Guidance

One of the most promising developments for reducing nerve block failure is artificial intelligence applied to real-time ultrasound imaging. Even experienced clinicians can struggle to identify nerves on ultrasound, especially in patients with challenging anatomy. AI systems trained on thousands of ultrasound images can highlight anatomical structures in real time, flag the nerve’s position, and assist with needle tracking as the injection happens.¹⁹

Early evidence is encouraging. A scoping review of AI-assisted ultrasound guidance found statistically significant improvements in correct identification of the block view and anatomical structures, along with reductions in needle adjustments and accidental bone contacts compared to standard ultrasound guidance alone.²⁰ Another accuracy study found that AI-based anatomy identification software could successfully interpret structures in real-time sonography and was particularly useful for less experienced practitioners.²¹ The technology is still in its earlier stages of clinical adoption, but it directly targets one of the most common failure modes: not putting the needle in the right place. If AI can help a clinician find the nerve faster and more reliably, the downstream benefit is fewer incomplete blocks, fewer repeat attempts, and less anesthetic used overall.

The gap between research demonstrations and routine clinical use is real, though. Most AI-assisted regional anesthesia tools have been tested in controlled settings rather than across the full range of patient body types and anatomical variants seen in everyday practice. How well they perform in obese patients, in areas with scar tissue, or in emergency settings where ultrasound conditions are suboptimal remains an open question. Still, this is the clearest technological path toward reducing the failure rates that have persisted even after ultrasound guidance became standard.